ARMP
Price
$0.96
Change
+$0.06 (+6.67%)
Updated
Apr 11 closing price
Capitalization
32.71M
26 days until earnings call
TSHA
Price
$1.25
Change
+$0.08 (+6.84%)
Updated
Apr 11 closing price
Capitalization
239.85M
25 days until earnings call
Ad is loading...

ARMP vs TSHA

Header iconARMP vs TSHA Comparison
Open Charts ARMP vs TSHABanner chart's image
Armata Pharmaceuticals
Price$0.96
Change+$0.06 (+6.67%)
Volume$31.39K
Capitalization32.71M
Taysha Gene Therapies
Price$1.25
Change+$0.08 (+6.84%)
Volume$867.48K
Capitalization239.85M
ARMP vs TSHA Comparison Chart
Loading...
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARMP vs. TSHA commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a Buy and TSHA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (ARMP: $0.96 vs. TSHA: $1.25)
Brand notoriety: ARMP and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 172% vs. TSHA: 41%
Market capitalization -- ARMP: $32.71M vs. TSHA: $239.85M
ARMP [@Biotechnology] is valued at $32.71M. TSHA’s [@Biotechnology] market capitalization is $239.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than ARMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARMP’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • ARMP’s TA Score: 4 bullish, 5 bearish.
  • TSHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than ARMP.

Price Growth

ARMP (@Biotechnology) experienced а -25.00% price change this week, while TSHA (@Biotechnology) price change was +2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

ARMP is expected to report earnings on May 08, 2025.

TSHA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($240M) has a higher market cap than ARMP($32.7M). TSHA YTD gains are higher at: -28.035 vs. ARMP (-48.108). ARMP has higher annual earnings (EBITDA): -31.21M vs. TSHA (-87.95M). TSHA has more cash in the bank: 139M vs. ARMP (17.1M). TSHA has less debt than ARMP: TSHA (63.2M) vs ARMP (140M). TSHA has higher revenues than ARMP: TSHA (8.33M) vs ARMP (0).
ARMPTSHAARMP / TSHA
Capitalization32.7M240M14%
EBITDA-31.21M-87.95M35%
Gain YTD-48.108-28.035172%
P/E RatioN/A2.70-
Revenue08.33M-
Total Cash17.1M139M12%
Total Debt140M63.2M222%
FUNDAMENTALS RATINGS
ARMP: Fundamental Ratings
ARMP
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARMPTSHA
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
85%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
77%
View a ticker or compare two or three
Ad is loading...
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ATHWX16.56N/A
N/A
American Century Heritage R
RRGTX6.62N/A
N/A
DWS RREEF Global Real Estate Secc S
SWANX20.90N/A
N/A
Schwab Core Equity
MMMPX20.05N/A
N/A
Morgan Stanley Inst Emerging Mkts R6
LSVFX9.99N/A
N/A
LSV Global Managed Volatility Instl

ARMP and

Correlation & Price change

A.I.dvisor tells us that ARMP and NXTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARMP and NXTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
+6.19%
NXTC - ARMP
31%
Poorly correlated
+7.78%
TSHA - ARMP
25%
Poorly correlated
+6.41%
SRRK - ARMP
25%
Poorly correlated
+6.42%
RAPT - ARMP
24%
Poorly correlated
+1.59%
MGTX - ARMP
24%
Poorly correlated
+2.56%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+6.41%
LOGC - TSHA
45%
Loosely correlated
-1.93%
ALT - TSHA
38%
Loosely correlated
+6.01%
VYGR - TSHA
37%
Loosely correlated
+6.02%
DNTH - TSHA
36%
Loosely correlated
+12.88%
COGT - TSHA
36%
Loosely correlated
+5.97%
More